Zymedyne is pleased to announce that Co-founder Dr.Gerald Zamponi has received a “Parex Innovation Fellowship” from the University of Calgary for his outstanding work on T-type channels and pain research. This fellowship will help to provide funds for Zymedyne research and patenting costs associated with developing our novel pain therapeutics platform.
Read more about it here:
https://science.ucalgary.ca/research-innovation/innovation/parex-innovation-fellows/gerald-zamponi
